Gria3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| GRIA3 Protein | |
|---|---|
| Protein Name | Glutamate Ionotropic Receptor AMPA Type Subunit 3 (GluA3) |
| Gene | GRIA3 |
| UniProt ID | P42263 |
| Molecular Weight | ~98 kDa |
| Subcellular Localization | Postsynaptic membrane, synapse |
| Protein Family | AMPA receptor family, ionotropic glutamate receptor family |
GRIA3 encodes the glutamate ionotropic receptor AMPA type subunit 3 (GluA3), one of four AMPA receptor subunits (GluA1-4) that form ionotropic glutamate receptors in the central nervous system. AMPA receptors mediate fast excitatory synaptic transmission and are critical for synaptic plasticity, learning, and memory.
GluA3 is a transmembrane protein consisting of:
The ligand-binding domain contains the glutamate binding site, while the C-terminal tail interacts with PDZ domain proteins for synaptic targeting.
AMPA receptors containing GluA3 subunits mediate fast excitatory neurotransmission at the vast majority of synapses in the brain. These receptors are essential for:
GluA3-containing receptors show distinctive trafficking properties and are involved in synaptic scaling.
Reduced GRIA3 expression and altered AMPA receptor trafficking have been reported in AD brains. This may contribute to synaptic dysfunction and memory impairment.
Dysregulation of AMPA receptor function contributes to excitotoxicity in motor neurons. Altered GluA3 subunit composition may affect calcium permeability.
Pathogenic mutations in GRIA3 cause X-linked mental retardation with impaired synaptic plasticity.
Current therapeutic approaches include:
[1] AMPA receptor subunit expression in AD brain. Neurobiol Aging. 2003.[2] GRIA3 and X-linked mental retardation. Nat Genet. 2000.[3] AMPA receptor dysfunction in ALS. Exp Neurol. 2012.
The study of Gria3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] AMPA receptor subunit expression in AD brain. Neurobiol Aging. 2003.[2] GRIA3 and X-linked mental retardation. Nat Genet. 2000.[3] AMPA receptor dysfunction in ALS. Exp Neurol. 2012.